Undisclosed FXIa Inhibitor / University of California, Pfizer - LARVOL DELTA

Anticoagulation Management: Current Landscape and Future Trends. (PubMed, J Clin Med) - "The introduction of warfarin in the 1950s revolutionized anticoagulation by offering long-term oral regimens...This review highlights the ongoing innovation in anticoagulant development, the need for precise management, and potential future avenues like factor XIa inhibitors. Additionally, artificial intelligence holds promise for improving patient outcomes and addressing the complexities of thrombotic disease management by personalizing therapy and reducing bleeding risks."

Journal • Review • Cardiovascular • Hematological Disorders • Myocardial Infarction • Pulmonary Embolism • Respiratory Diseases • Thrombosis